J. S. Yadav et al. / Tetrahedron Letters 52 (2011) 2943–2945
2945
In continuation of our ongoing research programme on the total
synthesis of biologically active molecules by desymmetrization
strategy,6 and also the inherent biological property of bovidic acid
encouraged us to initiate the total synthesis of this molecule. Here-
in, we report a concise and flexible stereoselective synthetic route
for the total synthesis of (+)-bovidic acid (1) starting from the read-
1,7-heptanediol. The salient features of this synthesis include the
use of the MacMillan -hydroxylation and HWE reaction for the
construction of -hydroxy- ,b-unsaturated ester in a single step,
Grubbs cross metathesis and tandem Sharpless asymmetric
dihydroxylation-SN2 cyclization, which allow the preparation of a
target molecule in a short and flexible route.
a
c
a
ily available heptanediol by employing the MacMillan
ation, Horner–Wadsworth–Emmons olefination, cross metathesis
and tandem Sharpless asymmetric dihydroxylation-SN2
cyclization.
In our retrosynthetic analysis, we envisioned that the synthesis
of bovidic acid could be accomplished from intermediate 14, which
can be synthesized by means of cross metathesis of compound 12
and 1-decene. The compound 12 could in turn be obtained from 6
a-hydroxyl-
Acknowledgements
K.R. thanks CSIR, New Delhi and U.V.S.R. thanks UGC, New
Delhi, for the award of fellowships.
References and notes
1. Oliver, J. E.; Weldon, P. J.; Peterson, K. S.; Schmidt, W. F.; Debboun, M. Abstracts
of Papers, 225th ACS National Meeting, New Orleans, LA, USA, March 23-27,
2003.
by reduction and C1Wittig of compound 6. This
c-hydroxy-a,b-
unsaturated ester 6 can be prepared through MacMillan
a-hydrox-
ylation followed by Horner–Wadsworth–Emmons olefination of
the corresponding aldehyde (Scheme 1).
2. Hideki, I.; Sonja, K.; Yasuhiro, I.; Nina, B.; Koji, N.; Paul, J. W. J. Nat. Prod. 2004,
67, 1426.
3. Ito, S.; Endo, K.; Inoue, S.; Nozoe, T. Tetrahedron Lett. 1971, 12, 4011.
4. Tran, K.; Chauhan, K. R. Biopestic. Int. 2007, 3, 53.
5. Evans, P. A.; Leahy, D. K.; Andrews, W. J.; Uraguchi, D. Angew. Chem., Int. Ed.
2004, 43, 4788.
6. For recent publications see: (a) Yadav, J. S.; Satheesh, G.; Murthy, C. V. S. R. Org.
Lett. 2010, 12, 2544; (b) Yadav, J. S.; Rajender, V.; Gangadhar, Y. Org. Lett. 2010,
12, 348; (c) Yadav, J. S.; Mohapatra, D. K.; Hossain, S. S.; Dhara, S. Tetrahedron
Lett. 2010, 51, 3079; (d) Yadav, J. S.; Narasimhulu, G.; Reddy, N. M.; Reddy, B. V.
S. Tetrahedron Lett. 2010, 51, 1574.
Accordingly, our synthetic approach began with mono protec-
tion of 1,7-heptanediol with benzyl bromide using NaH and TBAI
to give mono-benzyl ether 4 in 90% yield.7 This monoprotected
alcohol 4 was subjected to Swern oxidation to afford the corre-
sponding aldehyde 5 in 88% yield.8 The direct catalytic asymmetric
aminoxylation of aldehyde 5 with nitrosobenzene using
as a catalyst gave an intermediate -oxyamino aldehyde with high
levels of enantioselectivity9,10 by means of
-oxidation. Subse-
L-proline
a
7. Jun, I. S.; Lee, J. W.; Sakamoto, S.; Yamaguchi, K.; Kimoon, K. Tetrahedron Lett.
2000, 41, 471.
a
8. Corey, E. J.; Marafat, A.; Laguzza, B. C. Tetrahedron Lett. 1981, 22, 3339.
9. Brown, S. P.; Brochu, M. P.; Sinz, C. J.; MacMillan, D. W. C. J. Am Chem. Soc. 2003,
125, 10808.
10. For other reports on proline-catalyzed oxidation of aldehydes see: (a)
Chandrasekhar, S.; Mahipal, B.; Kavitha, M. J. Org. Chem. 2009, 74, 9531; (b)
Zhong, G. Angew. Chem., Int. Ed. 2003, 42, 4247; (c) Hayashi, Y.; Yamaguchi, J.;
Hibino, K.; Shoji, M. Tetrahedron Lett. 2003, 44, 8293; (d) Chandrasekhar, S.;
Yaragorla, S. R.; Sreelakshmi, L. Tetrahedron Lett. 2007, 48, 7339; (e) Zhong, G.
Chem. Commun. 2004, 606.
11. (a) Yadav, J. S.; Reddy, U. V. S.; Anusha, B.; Reddy, B. V. S. Tetrahedron Lett. 2010,
51, 5529; (b) Sabitha, G.; Chandrashekhar, G.; Yadagiri, K.; Yadav, J. S.
Tetrahedron Lett. 2010, 51, 3824; (c) Yadav, J. S.; Reddy, U. V. S.; Reddy, B. V.
S. Tetrahedron Lett. 2009, 50, 5984; (d) Zhong, G.; Yu, Y. Org. Lett. 2004, 6, 1637;
(e) Mangion, I. K.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 3696; (f)
Varseev, G. N.; Maier, M. E. Org. Lett. 2007, 9, 1461.
quent olefination of aminoxy aldehyde under Horner–Wads-
worth–Emmons conditions followed by the cleavage of aminoxy
bond with Cu(OAc)2 in MeOH at room temperature gave the
droxy-
,b-unsaturated ester 6 (96% ee, HPLC) in 48% yield.11 The
selective reduction of the double bond in -hydroxy- ,b-unsatu-
c-hy-
a
c
a
12
rated ester 6 using NiCl2.6H2O and NaBH4 afforded the com-
pound 7 in 90% yield. Thereafter, alcohol 7 was protected as its
MOM ether 8 using MOMCl in the presence of the Hunig’s base
in dry dichloromethane. The reduction of ester 8 with DIBAL-H in
DCM gave the primary alcohol 9 in 88% yield, which was further
oxidized to aldehyde 10 under Swern oxidation conditions. Upon
treatment of aldehyde 10 with methylene-triphenylphosphorane
(generated in situ from CH3P+Ph3I- and n-BuLi) in THF gave the ole-
fin 11 in 85% yield. The deprotection of MOM ether was achieved
by p-TSA in methanol to give the secondary alcohol 12 in 90% yield.
The hydroxyl compound 12 was converted into its mesylate13 13
using MeSO2Cl, Et3N and DMAP (catalytic) in CH2Cl2. The mesyl es-
ter plays a dual role as a protecting group as well as a leaving group
at a later stage. Then substrate 13 was treated with 0.03 equiv of
second generation Grubbs’ catalyst in the presence of 4 equiv of
1-decene in dichloromethane for 10 h at reflux. The reaction pro-
ceeded smoothly and the desired cross coupled product 14 was ob-
tained in 75% yield as E/Z isomers in 15:1 ratio.14 A careful flash
chromatography on silica gel allowed the separation of the E and
Z isomers. The major trans isomer of cross metathesis product 14
was subjected to the Sharpless asymmetric dihydroxylation15
using (DHQD)2 PHAL, K3Fe(CN)6, K2CO3, and MeSONH2, in t-
BuOH/H2O (1:1) over 30 h to afford the key tetrahydrofuran 15
in 85% yield (no traces of the other isomer was detected by 1H
NMR, since no further experiments were carried out on the enan-
tiomerically pure compound.). Debenzylation of ether 15 with
10% Pd/C under H2 atmosphere gave the primary alcohol 16 in
good yield. Eventual oxidation of primary alcohol 16 using TEMPO
and BAIB in DCM/H2O(1:1) afforded the target acid 1 in 84% yield
as a semi-solid without affecting the secondary alcohol (Scheme
2).16 The analytical and spectral properties of the compound 1
were in good agreement with the data reported in literature.17
In conclusion, we have developed an efficient stereoselective
route for the total synthesis of bovidic acid from a readily available
12. Satoh, T.; Nanba, K.; Suzuki, S. Chem. Pharm. Bull. 1971, 19, 817.
13. Marshal, J. A.; Sabatini, J. J. Org. Lett. 2005, 7, 4819.
14. Grubbs, R. H. Handbook of Metathesis; Wiley-VCH: Germany, 2003; (b) Connon,
S. J.; Blechert, S. Angew. Chem., Int. Ed. 2003, 42, 1900; (c) Chatterjee, A. K.; Choi,
T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am. Chem. Soc. 2003, 125, 11360; (d)
Tetsuya, Y.; Hiroko, H.; Toshikazu, H.; Shigeo, K. Org. Lett. 2006, 8, 5569.
15. (a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.;
Jeong, K. S.; Kwong, H. L.; Morikawa, K.; Wang, Z. M.; Xu, D.; Zhang, X. L. J. Org.
Chem. 1992, 57, 2768; (b) Kolb, H. C.; Van-Nieuwenhze, M. S.; Sharpless, K. B.
Chem. Rev. 1994, 94, 2483; (c) Mohapatra, D. K.; Pavankumar, D.; Hasibur, R.;
Pal, R. Tetrahedron Lett. 2009, 50, 6276.
16. (a) Epp, J. B.; Widlanski, T. S. J. Org. Chem. 1999, 64, 293; (b) De Mico, A.;
Margarita, R.; Parlanti, L.; Vescovi, A.; Piancatelli, G. J. Org. Chem. 1997, 62,
6974.
17. Spectral data for compound 6: Light yellow liquid, ½a D25
ꢁ
+3 (c 0.75, CHCl3); IR
(neat): t ;
max 3430, 2922, 2852, 1717, 1655, 1641, 1262, 1096, 803, 737 cmꢀ1 1H
NMR (CDCl3, 300 MHz): d 7.29–7.21 (m, 5H), 6.87 (dd, 1H, J = 4.5, 15.8 Hz), 5.96
(dd, 1H, J = 1.5, 15.1 Hz), 4.4 (s, 2H), 4.21–4.11 (m, 3H), 3.42 (t, 2H, J = 6.0 Hz),
1.61–1.24 (m, 11H). 13C NMR (CDCl3, 75 MHz): d 166.5, 150.0, 138.5, 128.3,
127.6, 127.4, 120.1, 72.8, 70.9, 70.1, 60.4, 36.5, 29.5, 26.0, 24.9, 14.2; ESI-MS:
m/z: 307 (M+H)+, 324 (M+NH4)+, 329 (M+Na)+; Compound 15: Colourless
liquid, ½a 2D5
ꢁ
+8.4 (c 0.4, CHCl3); IR (neat): tmax 3449, 2922, 2852, 1637, 1461,
1098, 726 cmꢀ1
;
1H NMR (CDCl3, 300 MHz): d 7.30–7.27 (m, 5H), 4.46 (s, 2H),
3.89-3.81 (m, 1H), 3.72 (q, 1H, J = 7.5 Hz), 3.46–3.40 (m, 2H), 3.34–3.26 (m, 1H),
2.26–2.22 (m, 1H), 2.04–1.89 (m, 2H), 1.63–1.23 (m, 24H), 0.88 (t, 3H,
J = 6.9 Hz); 13C NMR (CDCl3, 75 MHz): d 128.3, 127.6, 127.4, 81.9, 79.1, 74.1,
72.8, 70.3, 35.6, 33.4, 32.5, 31.9, 30.2, 29.8, 29.6, 29.3, 28.4, 26.3, 26.1, 25.7,
22.7, 14.2; ESI-MS: m/z: 390 (M)+, 391 (M+H)+; Compound 1: Colourless semi
solid, ½a 2D5
ꢁ
+7.3 (c 0.2, CHCl3); IR (neat): tmax 3447, 2921, 2852, 1716, 1461,
1260, 1081, 722 cm-1
;
1H NMR (CDCl3, 300 MHz): d 3.93–3.83 (m, 1H), 3.74 (q,
1H, J = 7.5 Hz), 3.36–3.28 (m, 1H), 2.34 (t, 2H, J = 7.5 Hz), 2.09–1.90 (m, 2H),
1.69–1.32 (m, 12 H), 1.27 (s, 12H), 0.88 (t, 3H, J = 7.5 Hz); 13C NMR (CDCl3,
75 MHz): d 82.1, 78.9, 74.0, 35.3, 33.9, 33.5, 32.7, 32.1, 29.9, 29.8, 29.5, 28.6,
25.8, 25.7, 24.8, 22.9, 14.3; ESI-MS: m/z: 315 (M+H) +, 337 (M+Na)+.